TMCnet News
Advances in Cosmesis Increase Amputee Acceptance of Prosthesis and Orthotics Devices, Finds Frost & SullivanMOUNTAIN VIEW, California, Dec 12, 2012 (PR Newswire Europe via COMTEX) -- - Regulatory hurdles require efficient navigation for shorter time-to-market entry MOUNTAIN VIEW, California, Dec. 12, 2012 /PRNewswire/ -- The orthotics and prosthetics (O&P) industry is becoming a fertile ground for innovation because of the expanding patient pool of the elderly and disabled as well as numerous technological breakthroughs. The improving quality of O&P devices and services due to regular clinical interventions and integration of the interpreted data into patient care have considerably enhanced their uptake. New analysis from Frost & Sullivan's (http://www.technicalinsights.frost.com [http://www.ti.frost.com/]) Advances in Bionic Prosthesis and Orthotics finds that the O&P industry is experiencing a blend of multiple streams of science and technology. Consequently, market participants must strategize to align competencies, capabilities and resources to expand their market share. If you are interested in more information on this research, please email Britni Myers, Corporate Communications, at [email protected] [mailto:[email protected]], with your full name, company name, job title, telephone number, company email address, company website, city, state and country. "Advances in plastic fabrication, structures and materials help manufacturers produce better artificial limbs at a much quicker pace," said Technical Insights Research Analyst Saju John Mathew. "Further, the advent of microprocessors has transformed the overall prosthetics landscape." Currently, many versions of prosthesis can be developed to fit a patient's varying motor skills, facilitating better functionality and integration with the patient's needs. Superior cosmesis enables the matching of the prosthetics with the patient's sound side to camouflage any disability. However, there is always a risk of microbial infection during surgical insertion of a prosthetic in the body and this discourages its use. The Food and Drug Administration (FDA) can also peg back the newly conceived technology/product by delaying its commercial launch. In some instances, technology developers prefer to conduct their R&D overseas, citing regulatory delays. O&P devices, specifically related to neurostimulation technologies, are still at an early stage of commercialization. Developers need to ensure smoother regulatory approvals to attract investors and partners, and to gain global market shares. As the technology gets smarter and new materials and structures are invented, biocompatibility issues will be resolved. Miniaturization will further enhance the appeal of O&P devices among patients and boost the technology's adoption. "A strong R&D network under one umbrella can help developers complement existing technologies and explore other applications," noted Mathew. "Additionally, a hassle-free R&D environment aids uninterrupted funding and technology transfer between partners to enhance the value of the developed technology/product." Advances in Bionic Prosthesis and Orthotics, part of the Technical Insights subscription, outlines the R&D platform and the necessary factors required for the growth of the O&P industry. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants. Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters and research services. About Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies Contact Us: Start the discussion [http://www.frost.com/prod/servlet/register-form.pag refpage=http%3A//www.frost.com/prod/servlet/frost-home.pag&SRC=Contact] Join Us: Join our community [http://www.frost.com/prod/servlet/register-form.pag refpage=http%3A//www.frost.com/prod/servlet/frost-home.pag&SRC=Join] Subscribe: Newsletter on "the next big thing" [http://www.frost.com/prod/servlet/register-form.pag refpage=http%3A//www.frost.com/prod/servlet/frost-home.pag&SRC=PRFooter] Register: Gain access to visionary innovation [http://www.frost.com/prod/servlet/register-form.pag refpage=http%3A//www.frost.com/prod/servlet/frost-home.pag&SRC=Register] Advances in Bionic Prosthesis and Orthotics D2F7-TI Contact: Britni Myers Corporate Communications - North America P: +1-210.477.8481 F: +1-210.348.1003 E: [email protected] [mailto:[email protected]] http://www.frost.com [http://www.frost.com/] http://www.technicalinsights.frost.com [http://www.technicalinsights.frost.com/] Web site: http://www.frost.com/ |